Membrane-proteoliposome structures (MPs) are useful in preparing patient-specific vaccines against specific white blood cell (WBC) malignancies. The inventive MPs typically contain a membrane component derived from a specific WBC. Other useful components include immunostimulators and exogenous lipids. The resulting vaccines are both patient- and malignancy-specific.

Biomira U.S.A., Inc.

Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes

Disclosed are a nonspecific immunostimulant composition, a preparation method thereof, and uses thereof. The composition includes 150 to 300 wt. parts of sodium silicate, 2.about.8 wt. parts of sodium thiosulfate, 0.5.about.2 wt. parts of sodium carbonate, 0.5.about.2 wt. parts of potassium chloride, 200.about.400 wt. parts of white sugar, and 300.about.400 wt. parts of water, based on 100 wt. parts of potassium carbonate. The composition exhibits excellent defense against the mortality caused by AIV H5N1, thus improving the survival of infected animals. As a supplement of a formulated feed mixture for farmed aquatic organisms, the composition provides excellent immunostimulation and disease resistance so as to decrease the mass mortality of aquatic organisms and to increase productivity. Particularly, when raised with a food in mixture with the composition, livestock and farmed aquatic organisms are immunologically improved so that they can endure and are protected against epidemic diseases caused by viruses and bacteria.

white/imunostimulator

Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes

Nonspecific immunostimulator composition, method of preparation the same, and its use

Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca